Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder

Mohammad M. Herzallah, Ahmed A. Moustafa, Joman Y. Natsheh, Omar A. Danoun, Jessica R. Simon, Yasin I. Tayem, Mahmud A. Sehwail, Ivona Amleh, Issam Bannoura, Georgios Petrides, Catherine E. Myers, Mark A. Gluck

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To better understand how medication status and task demands affect cognition in major depressive disorder (MDD), we evaluated medication-naïve patients with MDD, medicated patients with MDD receiving the selective serotonin reuptake inhibitors (SSRI) paroxetine, and healthy controls. All three groups were administered a computer-based cognitive task with two phases, an initial phase in which a sequence is learned through reward-based feedback (which our prior studies suggest is striatal-dependent), followed by a generalization phase that involves a change in the context where learned rules are to be applied (which our prior studies suggest is hippocampal-region dependent). Medication-naïve MDD patients were slow to learn the initial sequence but were normal on subsequent generalization of that learning. In contrast, medicated patients learned the initial sequence normally, but were impaired at the generalization phase. We argue that these data suggest (i) an MDD-related impairment in striatal-dependent sequence learning which can be remediated by SSRIs and (ii) an SSRI-induced impairment in hippocampal-dependent generalization of past learning to novel contexts, not otherwise seen in the medication-naïve MDD group. Thus, SSRIs might have a beneficial effect on striatal function required for sequence learning, but a detrimental effect on the hippocampus and other medial temporal lobe structures is critical for generalization.

Original languageEnglish (US)
Pages (from-to)484-492
Number of pages9
JournalJournal of Affective Disorders
Volume151
Issue number2
DOIs
StatePublished - Nov 1 2013

Fingerprint

Paroxetine
Major Depressive Disorder
Serotonin Uptake Inhibitors
Learning
Depression
Corpus Striatum
Temporal Lobe
Reward
Cognition
Generalization (Psychology)
Hippocampus

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Psychiatry and Mental health

Keywords

  • Basal ganglia Sequence learning
  • Generalization
  • Hippocampus
  • Major depressive disorder
  • Selective serotonin reuptake inhibitor (SSRI)

Cite this

Herzallah, Mohammad M. ; Moustafa, Ahmed A. ; Natsheh, Joman Y. ; Danoun, Omar A. ; Simon, Jessica R. ; Tayem, Yasin I. ; Sehwail, Mahmud A. ; Amleh, Ivona ; Bannoura, Issam ; Petrides, Georgios ; Myers, Catherine E. ; Gluck, Mark A. / Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. In: Journal of Affective Disorders. 2013 ; Vol. 151, No. 2. pp. 484-492.
@article{66fb151904ac43f2aa62120e52199d7e,
title = "Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder",
abstract = "To better understand how medication status and task demands affect cognition in major depressive disorder (MDD), we evaluated medication-na{\"i}ve patients with MDD, medicated patients with MDD receiving the selective serotonin reuptake inhibitors (SSRI) paroxetine, and healthy controls. All three groups were administered a computer-based cognitive task with two phases, an initial phase in which a sequence is learned through reward-based feedback (which our prior studies suggest is striatal-dependent), followed by a generalization phase that involves a change in the context where learned rules are to be applied (which our prior studies suggest is hippocampal-region dependent). Medication-na{\"i}ve MDD patients were slow to learn the initial sequence but were normal on subsequent generalization of that learning. In contrast, medicated patients learned the initial sequence normally, but were impaired at the generalization phase. We argue that these data suggest (i) an MDD-related impairment in striatal-dependent sequence learning which can be remediated by SSRIs and (ii) an SSRI-induced impairment in hippocampal-dependent generalization of past learning to novel contexts, not otherwise seen in the medication-na{\"i}ve MDD group. Thus, SSRIs might have a beneficial effect on striatal function required for sequence learning, but a detrimental effect on the hippocampus and other medial temporal lobe structures is critical for generalization.",
keywords = "Basal ganglia Sequence learning, Generalization, Hippocampus, Major depressive disorder, Selective serotonin reuptake inhibitor (SSRI)",
author = "Herzallah, {Mohammad M.} and Moustafa, {Ahmed A.} and Natsheh, {Joman Y.} and Danoun, {Omar A.} and Simon, {Jessica R.} and Tayem, {Yasin I.} and Sehwail, {Mahmud A.} and Ivona Amleh and Issam Bannoura and Georgios Petrides and Myers, {Catherine E.} and Gluck, {Mark A.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.jad.2013.06.030",
language = "English (US)",
volume = "151",
pages = "484--492",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "2",

}

Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. / Herzallah, Mohammad M.; Moustafa, Ahmed A.; Natsheh, Joman Y.; Danoun, Omar A.; Simon, Jessica R.; Tayem, Yasin I.; Sehwail, Mahmud A.; Amleh, Ivona; Bannoura, Issam; Petrides, Georgios; Myers, Catherine E.; Gluck, Mark A.

In: Journal of Affective Disorders, Vol. 151, No. 2, 01.11.2013, p. 484-492.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder

AU - Herzallah, Mohammad M.

AU - Moustafa, Ahmed A.

AU - Natsheh, Joman Y.

AU - Danoun, Omar A.

AU - Simon, Jessica R.

AU - Tayem, Yasin I.

AU - Sehwail, Mahmud A.

AU - Amleh, Ivona

AU - Bannoura, Issam

AU - Petrides, Georgios

AU - Myers, Catherine E.

AU - Gluck, Mark A.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - To better understand how medication status and task demands affect cognition in major depressive disorder (MDD), we evaluated medication-naïve patients with MDD, medicated patients with MDD receiving the selective serotonin reuptake inhibitors (SSRI) paroxetine, and healthy controls. All three groups were administered a computer-based cognitive task with two phases, an initial phase in which a sequence is learned through reward-based feedback (which our prior studies suggest is striatal-dependent), followed by a generalization phase that involves a change in the context where learned rules are to be applied (which our prior studies suggest is hippocampal-region dependent). Medication-naïve MDD patients were slow to learn the initial sequence but were normal on subsequent generalization of that learning. In contrast, medicated patients learned the initial sequence normally, but were impaired at the generalization phase. We argue that these data suggest (i) an MDD-related impairment in striatal-dependent sequence learning which can be remediated by SSRIs and (ii) an SSRI-induced impairment in hippocampal-dependent generalization of past learning to novel contexts, not otherwise seen in the medication-naïve MDD group. Thus, SSRIs might have a beneficial effect on striatal function required for sequence learning, but a detrimental effect on the hippocampus and other medial temporal lobe structures is critical for generalization.

AB - To better understand how medication status and task demands affect cognition in major depressive disorder (MDD), we evaluated medication-naïve patients with MDD, medicated patients with MDD receiving the selective serotonin reuptake inhibitors (SSRI) paroxetine, and healthy controls. All three groups were administered a computer-based cognitive task with two phases, an initial phase in which a sequence is learned through reward-based feedback (which our prior studies suggest is striatal-dependent), followed by a generalization phase that involves a change in the context where learned rules are to be applied (which our prior studies suggest is hippocampal-region dependent). Medication-naïve MDD patients were slow to learn the initial sequence but were normal on subsequent generalization of that learning. In contrast, medicated patients learned the initial sequence normally, but were impaired at the generalization phase. We argue that these data suggest (i) an MDD-related impairment in striatal-dependent sequence learning which can be remediated by SSRIs and (ii) an SSRI-induced impairment in hippocampal-dependent generalization of past learning to novel contexts, not otherwise seen in the medication-naïve MDD group. Thus, SSRIs might have a beneficial effect on striatal function required for sequence learning, but a detrimental effect on the hippocampus and other medial temporal lobe structures is critical for generalization.

KW - Basal ganglia Sequence learning

KW - Generalization

KW - Hippocampus

KW - Major depressive disorder

KW - Selective serotonin reuptake inhibitor (SSRI)

UR - http://www.scopus.com/inward/record.url?scp=84885478623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885478623&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2013.06.030

DO - 10.1016/j.jad.2013.06.030

M3 - Article

C2 - 23953023

AN - SCOPUS:84885478623

VL - 151

SP - 484

EP - 492

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 2

ER -